|
Market Closed -
NYSE
04:00:02 2026-10-15 pm EDT
|
Pre-market 08:10:11 am | |||
| 166.68 USD | +2.87% |
|
167.04 | +0.22% |
| 07:13am | UK stocks set for weekly gains as investors seek shelter in defensive sectors | RE |
| 07:02am | Berenberg Raises Launch Probability, Peak Sales Estimate for AstraZeneca's Hypophosphatasia Therapy | MT |
| Market Cap | 261B 233B 217B 197B 371B 24,720B 377B 2,601B 1,018B 12,898B 979B 959B 41,272B | P/E 2026 * |
22x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 281B 251B 233B 212B 399B 26,598B 406B 2,798B 1,095B 13,878B 1,054B 1,032B 44,408B | EV / Sales 2026 * |
4.43x | EV / Sales 2027 * | 4.05x |
| Free-Float |
96.62% | Yield 2026 * |
1.99% | Yield 2027 * | 2.11% |
Last Transcript: AstraZeneca PLC
| 1 day | +0.22% | ||
| Current month | +79.67% | ||
| Current year | +81.31% |
| Current year | 89.04 |  | 169.81 |
| 1 year | 80.48 | | 169.81 |
| 3 years | 60.47 | | 169.81 |
| 5 years | 52.65 | | 169.81 |
| 10 years | 25.55 | | 169.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.87% | +4.98% | - | - | 261B | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,116B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 610B | |
| -0.03% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 358B | |
| -1.15% | +5.11% | +31.83% | +49.16% | 366B | |
| -1.51% | +4.18% | +18.92% | +42.29% | 288B | |
| -1.94% | +3.82% | -0.78% | +13.53% | 261B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 235B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 195B | |
| Average | +0.01% | +5.27% | +34.53% | +62.05% | 436.64B | |
| Weighted average by Cap. | +0.29% | +4.93% | +38.17% | +71.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.4B 56.59B 52.6B 47.84B 90.01B 6,005B 91.63B 632B 247B 3,133B 238B 233B 10,026B | 67.37B 60.13B 55.89B 50.84B 95.64B 6,381B 97.37B 671B 263B 3,329B 253B 247B 10,653B |
| Net income | 11.81B 10.54B 9.79B 8.91B 16.76B 1,118B 17.06B 118B 46.03B 583B 44.3B 43.36B 1,867B | 13.73B 12.25B 11.39B 10.36B 19.49B 1,300B 19.84B 137B 53.53B 678B 51.52B 50.43B 2,171B |
| Net Debt | 19.83B 17.7B 16.45B 14.96B 28.15B 1,878B 28.66B 198B 77.32B 980B 74.42B 72.84B 3,136B | 12.02B 10.73B 9.97B 9.07B 17.06B 1,138B 17.37B 120B 46.85B 594B 45.09B 44.14B 1,900B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | $166.68 | +2.87% | 4,404,063 |
| 26-10-14 | $162.03 | +3.99% | 3,333,925 |
| 26-10-13 | $155.82 | -1.59% | 3,112,422 |
| 26-10-12 | $158.33 | -0.55% | 2,855,694 |
| 26-10-09 | $159.20 | +0.26% | 2,121,775 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
